Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

NCT00297739 is registered in ClinicalTrials.gov with Armenteros, Jorge L., M.D., P.A. as lead sponsor.

NCT NCT00297739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Augmentation for Treatment-Resistant Aggression in ADHD
Lead sponsor
Armenteros, Jorge L., M.D., P.A.
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2003
Completion date
April 30, 2005
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aggression